These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
898 related articles for article (PubMed ID: 29946734)
1. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Viswanathan M; Reddy S; Berkman N; Cullen K; Middleton JC; Nicholson WK; Kahwati LC JAMA; 2018 Jun; 319(24):2532-2551. PubMed ID: 29946734 [TBL] [Abstract][Full Text] [Related]
2. Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools. Gates M; Pillay J; Nuspl M; Wingert A; Vandermeer B; Hartling L Syst Rev; 2023 Mar; 12(1):51. PubMed ID: 36945065 [TBL] [Abstract][Full Text] [Related]
3. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. ; Curry SJ; Krist AH; Owens DK; Barry MJ; Caughey AB; Davidson KW; Doubeni CA; Epling JW; Kemper AR; Kubik M; Landefeld CS; Mangione CM; Phipps MG; Pignone M; Silverstein M; Simon MA; Tseng CW; Wong JB JAMA; 2018 Jun; 319(24):2521-2531. PubMed ID: 29946735 [TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates in multiple myeloma: a network meta-analysis. Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review. Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947 [TBL] [Abstract][Full Text] [Related]
6. Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials. Deardorff WJ; Cenzer I; Nguyen B; Lee SJ JAMA Intern Med; 2022 Jan; 182(1):33-41. PubMed ID: 34807231 [TBL] [Abstract][Full Text] [Related]
7. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation. Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816 [TBL] [Abstract][Full Text] [Related]
8. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. Levis S; Theodore G J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221 [TBL] [Abstract][Full Text] [Related]
10. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. Kahwati LC; Weber RP; Pan H; Gourlay M; LeBlanc E; Coker-Schwimmer M; Viswanathan M JAMA; 2018 Apr; 319(15):1600-1612. PubMed ID: 29677308 [TBL] [Abstract][Full Text] [Related]
11. Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis. Nayak S; Greenspan SL J Am Geriatr Soc; 2017 Mar; 65(3):490-495. PubMed ID: 28304090 [TBL] [Abstract][Full Text] [Related]
13. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial. Miller PD; Hattersley G; Riis BJ; Williams GC; Lau E; Russo LA; Alexandersen P; Zerbini CA; Hu MY; Harris AG; Fitzpatrick LA; Cosman F; Christiansen C; JAMA; 2016 Aug; 316(7):722-33. PubMed ID: 27533157 [TBL] [Abstract][Full Text] [Related]
14. Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. Händel MN; Cardoso I; von Bülow C; Rohde JF; Ussing A; Nielsen SM; Christensen R; Body JJ; Brandi ML; Diez-Perez A; Hadji P; Javaid MK; Lems WF; Nogues X; Roux C; Minisola S; Kurth A; Thomas T; Prieto-Alhambra D; Ferrari SL; Langdahl B; Abrahamsen B BMJ; 2023 May; 381():e068033. PubMed ID: 37130601 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses. Zhou J; Ma X; Wang T; Zhai S Osteoporos Int; 2016 Nov; 27(11):3289-3300. PubMed ID: 27273112 [TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis. Simpson EL; Martyn-St James M; Hamilton J; Wong R; Gittoes N; Selby P; Davis S Bone; 2020 Jan; 130():115081. PubMed ID: 31626995 [TBL] [Abstract][Full Text] [Related]
17. Screening for Vitamin D Deficiency in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Kahwati LC; LeBlanc E; Weber RP; Giger K; Clark R; Suvada K; Guisinger A; Viswanathan M JAMA; 2021 Apr; 325(14):1443-1463. PubMed ID: 33847712 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials. Chen L; Wang G; Zheng F; Zhao H; Li H Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731 [TBL] [Abstract][Full Text] [Related]